丙型肝炎清除后对既往乙型肝炎疫苗无应答者进行再接种
研究前瞻性招募既往HBV疫苗无应答的慢性HCV患者,在HCV清除后再接种,完成系列接种后1个月检测HBsAb。34例入组者中31例完成随访检测,21例(67.7%)呈反应性;HBsAb反应性与年龄、性别、种族或晚期纤维化存在与否均无显著差异。作者认为HCV治愈后应考虑对HBV疫苗无应答者再接种。
要点
- HCV清除后再接种,31例完成检测者中21例(67.7%)HBsAb呈反应性。
- HBsAb反应性与年龄、性别、种族或晚期纤维化均无显著差异。
- 作者认为HBV疫苗无应答者应在HCV治愈后考虑再接种。
核心结论
- 作者认为,HBV疫苗无应答者应在HCV治愈后考虑再接种。
研究设计与样本
- 前瞻性招募既往HBV疫苗无应答者,在HCV清除后进行再接种,完成系列接种后1个月检测HBsAb。
主要发现
- 34例入组患者中31例完成随访HBsAb检测,其中21例(67.7%)呈反应性。
- HBsAb反应性基于年龄、性别、种族或晚期纤维化存在与否均无显著差异。
临床怎么用
- 作者认为,既往HBV疫苗无应答的慢性HCV患者,在HCV治愈后可考虑再接种。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with chronic hepatitis C virus (HCV) do not respond to hepatitis B virus (HBV) vaccination as efficiently as the general population. We assessed if revaccination after HCV treatment resulted in improved response. METHODS: Previous HBV vaccine nonresponders were prospectively recruited for revaccination after HCV eradication. Hepatitis B surface antibody (HBsAb) testing was performed 1 month after series completion. RESULTS: Follow-up HBsAb testing was performed in 31 of 34 enrolled patients with 21 (67.7%) reactive results. There were no significant differences in HBsAb reactivity based on age, sex, race, or advanced fibrosis presence. CONCLUSIONS: HBV vaccine nonresponders should be considered for revaccination following HCV cure.
引用
- Powell JG, Goble SR, Debes JD, et al. Revaccination for Hepatitis B in Previous Nonresponders Following Hepatitis C Eradication. J Infect Dis. 2024. PMID: 37523757. doi:10.1093/infdis/jiad301
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。